Business Description
![VolitionRX Ltd VolitionRX Ltd logo](https://static.gurufocus.com/logos/0C00000Z04.png?14)
VolitionRX Ltd
NAICS : 325413
SIC : 2836
ISIN : US9286611077
Description
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.12 | |||||
Equity-to-Asset | -0.8 | |||||
Debt-to-Equity | -0.36 | |||||
Debt-to-EBITDA | -0.17 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -21.32 | |||||
Beneish M-Score | -5.61 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -4 | |||||
3-Year EPS without NRI Growth Rate | -3.3 | |||||
3-Year FCF Growth Rate | 12.8 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 53.44 | |||||
9-Day RSI | 46.85 | |||||
14-Day RSI | 45.37 | |||||
6-1 Month Momentum % | -37.32 | |||||
12-1 Month Momentum % | -48.43 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.43 | |||||
Quick Ratio | 0.43 | |||||
Cash Ratio | 0.37 | |||||
Days Sales Outstanding | 66.5 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -19 | |||||
Shareholder Yield % | -38.33 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -4426.47 | |||||
Net Margin % | -4379.67 | |||||
FCF Margin % | -2336.51 | |||||
ROA % | -157.19 | |||||
ROIC % | -154.74 | |||||
ROC (Joel Greenblatt) % | -591.73 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 64.5 | |||||
EV-to-EBIT | -1.35 | |||||
EV-to-EBITDA | -1.41 | |||||
EV-to-Revenue | 59.3 | |||||
EV-to-Forward-Revenue | 23.16 | |||||
EV-to-FCF | -2.54 | |||||
Earnings Yield (Greenblatt) % | -74.07 | |||||
FCF Yield % | -34.81 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:VNRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
VolitionRX Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.797 | ||
EPS (TTM) ($) | -0.46 | ||
Beta | 1.09 | ||
Volatility % | 80.47 | ||
14-Day RSI | 45.37 | ||
14-Day ATR ($) | 0.051461 | ||
20-Day SMA ($) | 0.66385 | ||
12-1 Month Momentum % | -48.43 | ||
52-Week Range ($) | 0.55 - 1.55 | ||
Shares Outstanding (Mil) | 82.93 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
VolitionRX Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
VolitionRX Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
VolitionRX Ltd Frequently Asked Questions
What is VolitionRX Ltd(VNRX)'s stock price today?
The current price of VNRX is $0.65. The 52 week high of VNRX is $1.55 and 52 week low is $0.55.
When is next earnings date of VolitionRX Ltd(VNRX)?
The next earnings date of VolitionRX Ltd(VNRX) is 2024-08-15 Est..
Does VolitionRX Ltd(VNRX) pay dividends? If so, how much?
VolitionRX Ltd(VNRX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |